BSECompany Update19 Oct 2026 · 19 Oct 2026, 12:54 pm

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for in-principle approval

Choksi Laboratories Ltd · 526546

✦ AI SummaryFundraise

Choksi Laboratories Ltd has informed that the proposed preferential issue of convertible warrants was not approved by shareholders and will not be proceeded with.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Choksi Laboratories Ltd - 526546 - Announcement under Regulation 30 (LODR)-Preferential Issue

Attachments (1)

📄

0038a0c9-47da-4c58-905a-8be6572aa0e9.pdf

pdf

Download →
View document text
Corporate Office & Central Laboratory: Survey No.9/1, Near Tulsiyana Industrial Park, Gram Kumedi-453555 (MP) INDIA Tel: +91 0731-3501112 Email: compliance_officer@choksilab.in Website: www.choksilab.in CIN: L85195MP1993PLC007471 To, Date: 19th October, 2026 The General Manager BSE Limited Corporate Relationship Department P. J. Towers, Dalal Street, Mumbai – 400001 Ref: Scrip Code: 526546, ISIN: INE493D01013 Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding non-approval of the proposed preferential issue of convertible warrants and request for closure of application for in-principle approval Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the proposal for issuance of convertible warrants on a preferential basis, as placed before the shareholders of Choksi Laboratories Limited (“the Company”) at the Extra-Ordinary General Meeting held on Saturday, October 17, 2026, has not been approved by the shareholders of the Company. Consequently, the proposed preferential issue of convertible warrants will not be proceeded with, and the Company shall not take any further steps in relation to the said proposal. It is further informed that the Promoters and the proposed allottees, in the proposed preferential issue of convertible warrants have abstained from voting on the said resolution at the EGM. In view of the above, we request BSE Limited to kindly close the application for in- principle approval submitted by the Company in connection with the aforesaid proposed preferential issue of convertible warrants. We request you to take the above information on record and do the needful. Thanking you, Yours faithfully, For CHOKSI LABORATORIES LIMITED PRAKHAR DUBEY Company Secretary & Compliance Officer M. No.: F14327